Can-Fite BioPharma
AboutSciencePipelineInvestor InformationContact Us

About Can-Fite BioPharma

About Us

Overview
Company Leadership
- Management
- Drug Dev. Team
- Board of Directors

 

Drug Development Team

William D. Kerns, DVM, MS, DACVP, VP Drug Development
Dr. Kerns has over 20 years of experience in pharmaceutical research and development at SmithKline Beecham and Eisai Pharmaceuticals. As a Senior Executive he has participated in the development of drugs for over 100 Phase I studies and 13 NDAs/MAAs. Dr. Kerns has chaired a U.S. FDA committee on biomarkers and he is an expert in preclinical development and regulatory strategy.
 
Michael Silverman, MD, Medical Director
Dr. Silverman has extensive experience in clinical development acquired through his involvement in clinical development in large pharmaceutical and small biopharmaceutical companies. He was involved in international clinical research, market-oriented strategic planning, and managed an R&D portfolio in various capacities at Sterling Winthrop Research Institute and subsequently at Sandoz Research Institute. 
 
Zivit Harpaz, MA, Director of Regulatory and Clinical Operations
Ms. Harpaz gained her M.A. at Haifa University, Israel. She has over 10 years of experience in clinical trial management where she led the logistic, regulatory and clinical monitoring affairs of Phase I/II, Phase II and Phase III clinical studies in the fields of oncology, ophthalmic, autoimmune Inflammatory and metabolic diseases.